Cargando…

GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 Genes

Genetic testing for BRCA1 and BRCA2 genes has led to the identification of many unique variants of uncertain significance (VUS). Multifactorial likelihood models that predict the odds ratio for VUS in favor or against cancer causality, have been developed, but their use is conditioned by the amount...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caleca, Laura, Colombo, Mara, van Overeem Hansen, Thomas, Lázaro, Conxi, Manoukian, Siranoush, Parsons, Michael T., Spurdle, Amanda B., Radice, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406614/ https://www.ncbi.nlm.nih.gov/pubmed/30696104 http://dx.doi.org/10.3390/cancers11020151

Ejemplares similares

Comparative In Vitro and In Silico Analyses of Variants in Splicing Regions of BRCA1 and BRCA2 Genes and Characterization of Novel Pathogenic Mutations
por: Colombo, Mara, et al.
Publicado: (2013)

Refinement of the assignment to the ACMG/AMP BS3 and PS3 criteria of eight BRCA1 variants of uncertain significance by integrating available functional data with protein interaction assays
por: Caleca, Laura, et al.
Publicado: (2023)

Characterization of an Italian Founder Mutation in the RING-Finger Domain of BRCA1
por: Caleca, Laura, et al.
Publicado: (2014)

Usefulness and Limitations of Comprehensive Characterization of mRNA Splicing Profiles in the Definition of the Clinical Relevance of BRCA1/2 Variants of Uncertain Significance
por: Gelli, Elisa, et al.
Publicado: (2019)

First description of an acinic cell carcinoma of the breast in a BRCA1 mutation carrier: a case report
por: Ripamonti, Carla B, et al.
Publicado: (2013)

The functional impact of variants of uncertain significance in BRCA2
por: Mesman, Romy L. S., et al.
Publicado: (2018)

Missense Variants of Uncertain Significance (VUS) Altering the Phosphorylation Patterns of BRCA1 and BRCA2
por: Tram, Eric, et al.
Publicado: (2013)

An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance
por: Iversen, Edwin S., et al.
Publicado: (2022)

BRCA1/2 Variants and Metabolic Factors: Results From a Cohort of Italian Female Carriers
por: Oliverio, Andreina, et al.
Publicado: (2020)

The Impact of Mediterranean Dietary Intervention on Metabolic and Hormonal Parameters According to BRCA1/2 Variant Type
por: Oliverio, Andreina, et al.
Publicado: (2022)

Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction
por: Caleca, Laura, et al.
Publicado: (2018)

Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohort
por: Li, Hongyan, et al.
Publicado: (2019)

BRCA1 and BRCA2 5′ noncoding region variants identified in breast cancer patients alter promoter activity and protein binding
por: Burke, Leslie J., et al.
Publicado: (2018)

The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study
por: Iqbal, Javaid, et al.
Publicado: (2016)

Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come?
por: Cheon, Jae Yeon, et al.
Publicado: (2014)

Federated analysis of BRCA1 and BRCA2 variation in a Japanese cohort
por: Casaletto, James, et al.
Publicado: (2022)

Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome
por: Fanale, Daniele, et al.
Publicado: (2021)

Next-Generation Sequencing in Order to Better Characterize a BRCA Variant of Uncertain Significance
por: Sorscher, Steven, et al.
Publicado: (2017)

Erratum: Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome
Publicado: (2022)

Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance
por: Richardson, Marcy E., et al.
Publicado: (2021)

miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer
por: Crippa, Elisabetta, et al.
Publicado: (2014)

Adherence to Mediterranean Diet and Metabolic Syndrome in BRCA Mutation Carriers
por: Bruno, Eleonora, et al.
Publicado: (2017)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
por: Cline, Melissa S., et al.
Publicado: (2018)

Clinical significance of large rearrangements in BRCA1 and BRCA2
por: Judkins, Thaddeus, et al.
Publicado: (2012)

Assessing BRCA1 activity in DNA damage repair using human induced pluripotent stem cells as an approach to assist classification of BRCA1 variants of uncertain significance
por: Ozgencil, Meryem, et al.
Publicado: (2021)

Whole Exome Sequencing Suggests Much of Non-BRCA1/BRCA2 Familial Breast Cancer Is Due to Moderate and Low Penetrance Susceptibility Alleles
por: Gracia-Aznarez, Francisco Javier, et al.
Publicado: (2013)

Revertant mosaicism for family mutations is not observed in BRCA1/2 phenocopies
por: Azzollini, Jacopo, et al.
Publicado: (2017)

Split-GFP Reassembly Assay: Strengths and Caveats from a Multiparametric Analysis
por: Bignon, Christophe, et al.
Publicado: (2022)

Multifactorial Likelihood Assessment of BRCA1 and BRCA2 Missense Variants Confirms That BRCA1:c.122A>G(p.His41Arg) Is a Pathogenic Mutation
por: Whiley, Phillip J., et al.
Publicado: (2014)

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
por: O’Mahony, Denise G., et al.
Publicado: (2023)

Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants
por: Momozawa, Yukihide, et al.
Publicado: (2022)

A Dietary Intervention to Lower Serum Levels of IGF-I in BRCA Mutation Carriers
por: Pasanisi, Patrizia, et al.
Publicado: (2018)

Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance
por: Lyra, Paulo C. M., et al.
Publicado: (2020)

Effect of BRCA2 sequence variants predicted to disrupt exonic splice enhancers on BRCA2 transcripts
por: Whiley, Phillip J, et al.
Publicado: (2010)

BRCA1 and BRCA2 Missense Variants of High and Low Clinical Significance Influence Lymphoblastoid Cell Line Post-Irradiation Gene Expression
por: Waddell, Nic, et al.
Publicado: (2008)

Analysis of BRCA1 and RAD51C Promoter Methylation in Italian Families at High-Risk of Breast and Ovarian Cancer
por: Tabano, Silvia, et al.
Publicado: (2020)

Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model
por: Azzollini, Jacopo, et al.
Publicado: (2022)

Quantifying BRCA1 and BRCA2 mRNA Isoform Expression Levels in Single Cells
por: Lattimore, Vanessa L., et al.
Publicado: (2019)

Detection of germline BRCA1 mutations by Multiple-Dye Cleavase Fragment Length Polymorphism (MD-CFLP) method
por: Casadei, S, et al.
Publicado: (2001)

In Vivo Protein–Protein Binding Competition Assay Based on Split-GFP Reassembly: Proof of Concept
por: Bignon, Christophe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mk62s0npoqlbq046fet2166rjq